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The big picture: How do our microbes
contribute to our health?

Propionate

Macrophages

Listeria monocytogenes

o Type of short chain fatty acid

o White blood cells

o Intracellular foodborne pathogen

o GRAS Food Preservative1

o Phagocytosis

o Common metabolite in
intestines

o Activation by cytokines and
antigens

o Infects the intestine cell lining
and spreads to peripheral organs

o Nutritional and regulatory
functions
1 Khaneghah, et al. (2017) Biotechnol Lett 39, 635–645. 2 CDC 2017

o 1,600 people in the U.S. become
sick from Listeria, and ~260 of
those people die2

3. Macrophages facilitate
the spread of Listeria to
other parts of the body.

steria
Ingestion of Li

1. Listeria may
encounter propionate
prior to infection in
food packaging.

2. Listeria, macrophages,
and propionate may all
come into contact in the
gut. Macrophages become
infected with Listeria.

Research question:
How does propionate affect
Listeria-macrophage
interactions?

General research approach: Studying effects of propionate
at different stages
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Method 1: Phagocytosis assay
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Cells were added to a 96
well plate. Each
treatment had 5 replicate
wells. The control had no
macrophages.
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Method 1: Phagocytosis assay
Propionate treatment at 0.1 mM but not 1 mM resulted in elevated phagocytic activity
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Summer 2019.
Data from 1 experiment.
5 replicates per treatment. Error
bars represent the standard
deviation.
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Method 2: Infection using a gentamicin protection assay with treatment of
macrophages and Listeria before and during Infection
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30 minute infection,
followed by wash
and gentamicin

2 hours post
infection, cells are
lysed and plated
The colony forming units
(CFU) are determined by
the number of colonies
that grow on the plate.

Method 2: Gentamicin protection assay with treatment of macrophages and
Listeria before and during infection
In aerobic, but not anaerobic conditions, macrophages and Listeria treated with 1 mM propionate
were associated with a decrease in intracellular CFU.
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Spring 2020.
Data from 1 experiment.
3 replicates for each treatment.
Error bars represent the
standard deviation.
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Method 3: Gentamicin protection assay with only pre-treatment of
macrophages and addition of Δhly mutants
Wild type Listeria

Δhly Listeria

• Hly encodes the listeriolysin O protein

• Does not produce LLO

• LLO binds to cholesterol on phagosomal

• Cannot escape the phagosome

membrane
• LLO oligomerizes in the membrane, forming a
pore

LLO

Method 3: Gentamicin protection assay with only pre-treatment of
macrophages and addition of hly mutants
Aerobically cultured Listeria that cannot produce LLO have a decreased survival in naïve
macrophages that are treated with propionate
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Fall 2020.
Average of 3 independent
experiments. Error bars
represent the SEM.
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Method 4: Gentamicin protection assay with pre-treatment of macrophages,
addition of hly mutants, and CFSE labelling
• Carboxyfluorescein succinimidyl ester is used to label
Listeria
• Fluorescence can be measured as an indicator of
phagocytic activity

Fluorescence
measured at
λ =521 nm and
λ
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emission
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Cells labelled with
CFSE

30 minute infection,
followed by wash and
gentamicin

2 hours post
infection, cells are
lysed and plated

Method 4: Gentamicin protection assay with pre-treatment of macrophages,
addition of hly mutants, and CFSE labelling
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Research Question: How
does propionate affect
Listeria-macrophage
interactions?
•

•
•

Propionate treatment of
macrophages and Listeria
resulted in decreased Listeria
survival
Propionate may have effects on
phagocytic activity in the
absence of infection
The effect of propionate on
macrophages is likely mediated
though antimicrobial activity at
the phagosome

Next Steps

Naive

• Determine effects of propionate on morphology
(Hannah DeRespiris)
• Publish conclusions abouts the effect of propionate
on macrophages and Listeria (Laura McFarland)

Activated
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